COGNITIVE IMPAIRMENT IN MULTIPLE SCLEROSIS: ASSOCIATION WITH THE ACTIVITY OF INFLAMMATORY PROCESS AND SEVERITY OF DISABILITY

Cover Page


Cite item

Full Text

Abstract

Background: Multiple sclerosis is the most common neurological disease leading to disability in young and productive patients. One of available methods of control over the course of the disease and detection of its progression is neuropsychological testing. However, selection of the most informative tests, as well as the search for interpretation of their results is still ongoing.

Aim: To study cognitive functions in multiple sclerosis patients depending on the disease activity and degree of disability.

Materials and methods: Fifty patients with multiple sclerosis were evaluated during their remissions and 15 of them were additionally assessed during an exacerbation. During neuropsychological testing a computer test “Selection of figures” was used for assessment of attention, productivity, frontal functions and visual neglect. We studied potential dependency of the parameters obtained from degree of disability and disease stage (exacerbation or remission). The control group comprised 12 healthy subjects.

Results: Compared to healthy subjects, the multiple sclerosis patients had a prolonged time of test performance, decreased learning, and statistically significant decrease of the working efficacy (p < 0.05). During an attack, there was a decreased conceptualization (48 answers compared to 51.5 at remission stage); more than 3-fold (from 1,3 to 4,4) increase in the number of figures missed in one visual field, that could indirectly indicate visual neglect. Also, changes in frontal functions were noted as a tendency to almost 2-fold higher numbers of perseverative answers, more frequent categorical escape and learning abnormality. There was a positive correlation between expanded disability scale score (EDSS) and working efficacy (r = 0.453, p = 0.001), and a negative correlation between EDSS and mental stability (r = 0.4055, p = 0.0035).

Conclusion: Patients with multiple sclerosis had abnormal rate and accuracy of test performance, compared to those in healthy subjects. During an exacerbation of the disease, there was a deterioration of the parameters compared to those registered in the remission. Also, a negative association with disease severity assessed by EDSS, was found. The data obtained documents feasibility of the computer test “Selection of figures” for dynamic control in multiple sclerosis patients.

About the authors

M. O. Sushkova

Moscow Regional Research and Clinical Institute (MONIKI)

Author for correspondence.
Email: FeliciaHardy@yandex.ru

Resident, Chair of Neurology, Postgraduate Training Faculty

Russian Federation

S. V. Kotov

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru

MD, PhD, Professor; Head of Department of Neurology; Head of Chair of Neurology, Postgraduate Training Faculty

Russian Federation

T. I. Yakushina

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru

PhD, Senior Research Fellow, Department of Neurology

Russian Federation

D. G. Lapitan

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru

Research Fellow, Medical Physics Laboratory

Russian Federation

References

  1. Шмидт ТЕ, Яхно НН. Рассеянный склероз: руководство для врачей. 3-е изд. М.: МЕД-пресс-информ; 2012. 272 с. Shmidt TE, Yakhno NN. Rasseyannyy skleroz: rukovodstvo dlya vrachey [Multiple sclerosis: manual for physicians]. 3rd ed. Moscow: MEDpress-inform; 2012. 272 p. (in Russian).
  2. Мешкова КС, Дамулин ИВ. Нарушения памяти при рассеянном склерозе. Журнал неврологии и психиатрии им. С.С. Корсакова. 2010;(9):8–13. Meshkova KS, Damulin IV. Narusheniya pamyatpri rasseyannom skleroze [Memory disorders imultiple sclerosis]. Zhurnal nevrologii i psikhiatriimeni S.S. Korsakova. 2010;110(9):8–13 (in Russian).
  3. Yildiz M, Tettenborn B, Radue EW, Bendfeldt K, Borgwardt S. Association of cognitive impairment and lesion volumes in multiple sclerosis – a MRI study. Clin Neurol Neurosurg. 2014;(127):54–8.
  4. Wallin MT, Wilken JA, Kane R. Cognitive dysfunction in multiple sclerosis: Assessment, imaging, and risk factors. J Rehabil Res Dev. 2006;43(1):63–72.
  5. Feinstein A, Kartsounis LD, Miller DH, Youl BD, Ron MA. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive, psychiatric and MRI follow up study. J Neurol Neurosurg Psychiatry. 1992;(55):869–76.
  6. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg- Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.
  7. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–52.
  8. Миланич АИ. Способ определения цветного зрения в численном виде и устройство для его реализации. Патент РФ № 2499543 от 04.02.2011Milanich AI. Sposob opredeleniya tsvetnozreniya v chislennom vide i ustroystvo dlya egrealizatsii [A method for quantitative determinatioof color vision and the device for itimplementation]. Patent of Russian FederatioNo. 2499543 dated 04.02.2011 (in Russian).
  9. Milanich AI. Physical сoncept of human eye. Journal of Physical Science and Application. 2013;3(2):86–92.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Sushkova M.O., Kotov S.V., Yakushina T.I., Lapitan D.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies